Governor Cuomo announced in his State of the State address yesterday that the University at Buffalo (UB) will partner with the New York Genome Center in Manhattan to accelerate recent advances in genomic medicine directly into clinical care. Partners include UB’s Center for Computational Research and its Institute for Healthcare Informatics, as well as Roswell Park Cancer Institute’s Center for Personalized Medicine. This major initiative continues to support Governor Cuomo’s mission to grow a high-tech corridor across New York State and revitalize upstate New York’s economy by leveraging the strengths of each region along with the state’s critical assets.
According to UB, the governor’s investment will spur further development of companies on the Buffalo Niagara Medical Campus that support genomic medicine, such as companies that will focus on diagnostics and information technology essential to breakthroughs in personalized medicine.
“This investment is testament to the growing reputation and resources available through UB, Roswell Park Cancer Institute, and the other institutions and life sciences companies on the Buffalo Niagara Medical Campus (BNMC) and will significantly aid our ability to grow and attract biotech, health and life science companies to Western New York,” said Matthew K. Enstice, President and Chief Executive Officer of the Buffalo Niagara Medical Campus, Inc. “We wp-contentlaud the Governor for implementing his vision and his continued investment in UB, the BNMC, and Western New York.